Showing results (61-70 of 358) with videos related to
Sort By:
Pageof 36
Journal of the National Cancer Institute|August 1, 1985
Studies of methotrexate-monoclonal antibody conjugates for immunotherapyJ Kanellos, G A Pietersz, I F McKenzieImmunity|March 14, 2000
Ly6d-L, a cell surface ligand for mouse Ly6dJ Apostolopoulos, I F McKenzie, M S SandrinJournal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj miceP X Xing, G Poulos, I F McKenzieCurrent Opinion in Molecular Therapeutics|March 16, 2001
MUC1 and breast cancerV Apostolopoulos, G A Pietersz, I F McKenzieThe Journal of Experimental Medicine|April 1, 1977
Ia antigenic specificities are oligosaccharide in nature: hapten-inhibition studiesI F McKenzie, A Clarke, C R ParishCancer Research|October 1, 1994
Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigensV Apostolopoulos, P X Xing, I F McKenzieJournal of Drug Targeting|May 20, 1998
In vitro and in vivo evaluation of human tumor necrosis factor-alpha (hTNFalpha) chemically conjugated to monoclonal antibodyG A Pietersz, B Toohey, I F McKenzieCancer Research|August 15, 1988
Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activityG A Pietersz, J Kanellos, I F McKenzieRedox Report : Communications in Free Radical Research|February 28, 2002
Development of a fecal occult blood test using a monoclonal antibody to haptoglobinP X Xing, G Young, I F McKenzieJournal of Molecular Medicine (Berlin, Germany)|July 30, 1999
Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapyV Apostolopoulos, M S Sandrin, I F McKenziePageof 36